SEARCH

SEARCH BY CITATION

References

  • 1000 Genomes Project Consortium, Abecasis, G. R., Auton, A., Brooks, L. D., DePristo, M. A., Durbin, R. M., Handsaker, R. E., Kang, H. M., Marth, G. T. & McVean, G. A. 2012. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 5665.
  • Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., Tabucchi, A., Carlucci, F., Eibl, M., Aker, M., Slavin, S., Al-Mousa, H., Al Ghonaium, A., Ferster, A., Duppenthaler, A., Notarangelo, L., Wintergerst, U., Buckley, R. H., Bregni, M., Marktel, S., Valsecchi, M. G., Rossi, P., Ciceri, F., Miniero, R., Bordignon, C. & Roncarolo, M.-G. 2009. Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N. Engl. J. Med. 360, 447458.
  • Aizawa, E., Hirabayashi, Y., Iwanaga, Y., Suzuki, K., Sakurai, K., Shimoji, M., Aiba, K., Wada, T., Tooi, N., Kawase, E., Suemori, H., Nakatsuji, N. & Mitani, K. 2012. Efficient and accurate homologous recombination in hESCs and hiPSCs using helper-dependent adenoviral vectors. Mol. Ther. 20, 424431.
  • Aoki, Y., Yokota, T. & Wood, M. J. A. 2013. Development of Multiexon Skipping Antisense Oligonucleotide Therapy for Duchenne Muscular Dystrophy. Biomed Res. Int. 2013, 18.
  • Arnould, S., Delenda, C., Grizot, S., Desseaux, C., Pâques, F., Silva, G. H. & Smith, J. 2011. The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy. Protein Eng. Des. Sel. 24, 2731.
  • Bacman, S. R., et al. 2013. Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs. Nat. Med. 19, 11111113.
  • Blake, D. J., Weir, A., Newey, S. E. & Davies, K. E. 2002. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291329.
  • Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., Cavallesco, R., Gillet-Legrand, B., Caccavelli, L., Sgarra, R., Maouche-Chrétien, L., Bernaudin, F., Girot, R., Dorazio, R., Mulder, G.-J., Polack, A., Bank, A., Soulier, J., Larghero, J., Kabbara, N., Dalle, B., Gourmel, B., Socie, G., Chrétien, S., Cartier, N., Aubourg, P., Fischer, A., Cornetta, K., Galacteros, F., Beuzard, Y., Gluckman, E., Bushman, F., Hacein-Bey-Abina, S. & Leboulch, P. 2010. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 467, 318322.
  • Chamberlain, J. R., Schwarze, U., Wang, P.-R., Hirata, R. K., Hankenson, K. D., Pace, J. M., Underwood, R. A., Song, K. M., Sussman, M., Byers, P. H. & Russell, D. W. 2004. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303, 11981201.
  • Chapdelaine, P., Pichavant, C., Rousseau, J., Pâques, F. & Tremblay, J. P. 2010. Meganucleases can restore the reading frame of a mutated dystrophin. Gene Ther. 17, 846858.
  • Choi, S. M., Kim, Y., Shim, J. S., Park, J. T., Wang, R.-H., Leach, S. D., Liu, J. O., Deng, C., Ye, Z. & Jang, Y.-Y. 2013. Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells. Hepatology 57, 24582468.
  • Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., Dickson, G., Wood, M. J. A., Wilton, S. D., Straub, V., Kole, R., Shrewsbury, S. B., Sewry, C., Morgan, J. E., Bushby, K. & Muntoni, F. 2011. Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378, 595605.
  • Cradick, T. J., Fine, E. J., Antico, C. J. & Bao, G. 2013. CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res. 41, 95849592.
  • Ding, Q., Lee, Y.-K., Schaefer, E. A. K., Peters, D. T., Veres, A., Kim, K., Kuperwasser, N., Motola, D. L., Meissner, T. B., Hendriks, W. T., Trevisan, M., Gupta, R. M., Moisan, A., Banks, E., Friesen, M., Schinzel, R. T., Xia, F., Tang, A., Xia, Y., Figueroa, E., Wann, A., Ahfeldt, T., Daheron, L., Zhang, F., Rubin, L. L., Peng, L. F., Chung, R. T., Musunuru, K. & Cowan, C. A 2013a. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell 12, 238251.
  • Ding, Q., Regan, S. N., Xia, Y., Oostrom, L. A., Cowan, C. A. & Musunuru, K. 2013b. Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs. Cell Stem Cell 12, 393394.
  • Ebina, H., Misawa, N., Kanemura, Y. & Koyanagi, Y. 2013. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci. Rep. 3, 2510.
  • Ellis, B. L., Hirsch, M. L., Porter, S. N., Samulski, R. J. & Porteus, M. H. 2013. Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs. Gene Ther. 20, 3542.
  • Ellis, J. & Bernstein, A. 1989. Gene targeting with retroviral vectors: recombination by gene conversion into regions of nonhomology. Mol. Cell. Biol. 9, 16211627.
  • Foster, H., Popplewell, L. & Dickson, G. 2012. Genetic Therapeutic Approaches for Duchenne Muscular Dystrophy. Hum. Gene Ther. 23, 676687.
  • Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K. & Sander, J. D. 2013. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822826.
  • Gabriel, R., Lombardo, A., Arens, A., Miller, J. C., Genovese, P., Kaeppel, C., Nowrouzi, A., Bartholomae, C. C., Wang, J., Friedman, G., Holmes, M. C., Gregory, P. D., Glimm, H., Schmidt, M., Naldini, L. & Von Kalle, C. 2011. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 29, 816823.
  • Gaj, T., Gersbach, C. A. & Barbas, C. F. 2013. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends Biotechnol. 31, 397405.
  • Goemans, N. M., Tulinius, M., Van Den Akker, J. T., Burm, B. E., Ekhart, P. F., Heuvelmans, N., Holling, T., Janson, A. A., Platenburg, G. J., Sipkens, J. A., Sitsen, J. M. A., Aartsma-Rus, A., Van Ommen, G.-J. B., Buyse, G., Darin, N., Verschuuren, J. J., Campion, G. V., De Kimpe, S. J. & Van Deutekom, J. C. 2011. Systemic administration of PRO051 in Duchenne's muscular dystrophy. N. Engl. J. Med. 364, 15131522.
  • Graw, J., Brackmann, H.-H., Oldenburg, J., Schneppenheim, R., Spannagl, M. & Schwaab, R. 2005. Haemophilia A: from mutation analysis to new therapies. Nat. Rev. Genet. 6, 488501.
  • Hacein-Bey-Abina, S., Hauer, J., Lim, A., Picard, C., Wang, G. P., Berry, C. C., Martinache, C., Rieux-Laucat, F., Latour, S., Belohradsky, B. H., Leiva, L., Sorensen, R., Debré, M., Casanova, J. L., Blanche, S., Durandy, A., Bushman, F. D., Fischer, A. & Cavazzana-Calvo, M. 2010. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 363, 355364.
  • Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., Mccormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J. I., De Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L. E., Wissler, M., Prinz, C., Rabbitts, T. H., Le Deist, F., Fischer, A. & Cavazzana-Calvo, M. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415419.
  • Händel, E.-M., Gellhaus, K., Khan, K., Bednarski, C., Cornu, T. I., Müller-Lerch, F., Kotin, R. M., Heilbronn, R. & Cathomen, T. 2012. Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors. Hum. Gene Ther. 23, 321329.
  • Hastings, P. J., Lupski, J. R., Rosenberg, S. M. & Ira, G. 2009. Mechanisms of change in gene copy number. Nat. Rev. Genet. 10, 551564.
  • Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., Dekelver, R. C., Katibah, G. E., Amora, R., Boydston, E. A., Zeitler, B., Meng, X., Miller, J. C., Zhang, L., Rebar, E. J., Gregory, P. D., Urnov, F. D. & Jaenisch, R. 2009. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851857.
  • Hockemeyer, D., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., Cost, G. J., Zhang, L., Santiago, Y., Miller, J. C., Zeitler, B., Cherone, J. M., Meng, X., Hinkley, S. J., Rebar, E. J., Gregory, P. D., Urnov, F. D. & Jaenisch, R.. 2011. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29, 731734.
  • Holkers, M., Maggio, I., Liu, J., Janssen, J. M., Miselli, F., Mussolino, C., Recchia, A., Cathomen, T. & Gonçalves, M. A. F. V. 2013. Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells. Nucleic Acids Res. 41, e63.
  • Holt, N., Wang, J., Kim, K., Friedman, G., Wang, X., Taupin, V., Crooks, G. M., Kohn, D. B., Gregory, P. D., Holmes, M. C. & Cannon, P. M. 2010. Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo. Nat. Biotechnol. 28, 839847.
  • Hotta, A. & Ellis, J. 2008. Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. J. Cell. Biochem. 105, 940948.
  • Hou, Z., Zhang, Y., Propson, N. E., Howden, S. E., Chu, L.-F., Sontheimer, E. J. & Thomson, J. A. 2013. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc. Natl Acad. Sci. USA 110, 1564415649.
  • Howden, S. E., Gore, A., Li, Z., Fung, H.-L., Nisler, B. S., Nie, J., Chen, G., Mcintosh, B. E., Gulbranson, D. R., Diol, N. R., Taapken, S. M., Vereide, D. T., Montgomery, K. D., Zhang, K., Gamm, D. M. & Thomson, J. A. 2011. Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc. Natl Acad. Sci. USA 108, 65376542.
  • Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., Cradick, T. J., Marraffini, L. A., Bao, G. & Zhang, F. 2013. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827832.
  • Irion, S., Luche, H., Gadue, P., Fehling, H. J., Kennedy, M. & Keller, G. 2007. Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat. Biotechnol. 25, 14771482.
  • Jiang, J., Jing, Y., Cost, G. J., Chiang, J.-C., Kolpa, H. J., Cotton, A. M., Carone, D. M., Carone, B. R., Shivak, D. A., Guschin, D. Y., Pearl, J. R., Rebar, E. J., Byron, M., Gregory, P. D., Brown, C. J., Urnov, F. D., Hall, L. L. & Lawrence, J. B. 2013a. Translating dosage compensation to trisomy 21. Nature 500, 296300.
  • Jiang, W., Bikard, D., Cox, D., Zhang, F. & Marraffini, L. A. 2013b. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31, 233239.
  • Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A. & Charpentier, E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816821.
  • Joung, J. K. & Sander, J. D. 2013. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 14, 4955.
  • Khan, I. F., Hirata, R. K., Wang, P.-R., Li, Y., Kho, J., Nelson, A., Huo, Y., Zavaljevski, M., Ware, C. & Russell, D. W. 2010. Engineering of human pluripotent stem cells by AAV-mediated gene targeting. Mol. Ther. 18, 11921199.
  • Kostrikis, L. G., Huang, Y., Moore, J. P., Wolinsky, S. M., Zhang, L., Guo, Y., Deutsch, L., Phair, J., Neumann, A. U. & Ho, D. D. 1998. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat. Med. 4, 350353.
  • Lamb, B. M., Mercer, A. C. & Barbas, C. F. 2013. Directed evolution of the TALE N-terminal domain for recognition of all 5′ bases. Nucleic Acids Res. 41, 97799785.
  • Lee, H. J., Kweon, J., Kim, E., Kim, S. & Kim, J.-S. 2012. Targeted chromosomal duplications and inversions in the human genome using zinc finger nucleases. Genome Res. 22, 539548.
  • Li, H., Haurigot, V., Doyon, Y., Li, T., Wong, S. Y., Bhagwat, A. S., Malani, N., Anguela, X. M., Sharma, R., Ivanciu, L., Murphy, S. L., Finn, J. D., Khazi, F. R., Zhou, S., Paschon, D. E., Rebar, E. J., Bushman, F. D., Gregory, P. D., Holmes, M. C. & High, K. A. 2011. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217221.
  • Li, L. B., Chang, K.-H., Wang, P.-R., Hirata, R. K., Papayannopoulou, T. & Russell, D. W. 2012. Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell 11, 615619.
  • Loman, N. J., Misra, R. V., Dallman, T. J., Constantinidou, C., Gharbia, S. E., Wain, J. & Pallen, M. J.. 2012. Performance comparison of benchtop high-throughput sequencing platforms. Nat. Biotechnol. 30, 434439.
  • Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., Holmes, M. C. & Naldini, L. 2007. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 12981306.
  • Lu, P., He, L., Ren, J., Chen, H., Rao, L., Zhuang, Q., Li, H., Li, L., Bao, L., He, J., Zhang, W., Zhu, F., Cui, C. & Xiao, L. 2013. Generating Hypoimmunogenic Human Embryonic Stem Cells by the Disruption of Beta 2-Microglobulin. Stem Cell Rev. 9, 806813.
  • Maier, D. A., Brennan, A. L., Jiang, S., Binder-Scholl, G. K., Lee, G., Plesa, G., Zheng, Z., Cotte, J., Carpenito, C., Wood, T., Spratt, S. K., Ando, D., Gregory, P., Holmes, M. C., Perez, E. E., Riley, J. L., Carroll, R. G., June, C. H. & Levine, B. L.. 2013. Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5. Hum. Gene Ther. 24, 245258.
  • Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L. & Church, G. M. 2013a. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833838.
  • Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., Dicarlo, J. E., Norville, J. E. & Church, G. M. 2013b. RNA-guided human genome engineering via Cas9. Science 339, 823826.
  • Meng, X., Noyes, M. B., Zhu, L. J., Lawson, N. D. & Wolfe, S. A. 2008. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat. Biotechnol. 26, 695701.
  • Mitani, K., Wakamiya, M., Hasty, P., Graham, F. L., Bradley, A. & Caskey, C. T. 1995. Gene targeting in mouse embryonic stem cells with an adenoviral vector. Somat. Cell Mol. Genet. 21, 221231.
  • Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., Mcintosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., O'Beirne, J., Smith, K., Pasi, J., Glader, B., Rustagi, P., Ng, C. Y. C., Kay, M. A., Zhou, J., Spence, Y., Morton, C. L., Allay, J., Coleman, J., Sleep, S., Cunningham, J. M., Srivastava, D., Basner-Tschakarjan, E., Mingozzi, F., High, K. A., Gray, J. T., Reiss, U. M., Nienhuis, A. W. & Davidoff, A. M. 2011. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 23572365.
  • Osborn, M. J., Starker, C. G., Mcelroy, A. N., Webber, B. R., Riddle, M. J., Xia, L., Defeo, A. P., Gabriel, R., Schmidt, M., Von Kalle, C., Carlson, D. F., Maeder, M. L., Joung, J. K., Wagner, J. E., Voytas, D. F., Blazar, B. R. & Tolar, J. 2013. TALEN-based gene correction for epidermolysis bullosa. Mol. Ther. 21, 11511159.
  • Ousterout, D. G., Perez-Pinera, P., Thakore, P. I., Kabadi, A. M., Brown, M. T., Qin, X., Fedrigo, O., Mouly, V., Tremblay, J. P. & Gersbach, C. A. 2013. Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients. Mol. Ther. 21, 17181726.
  • Palpant, N. J. & Dudzinski, D. 2013. Zinc finger nucleases: looking toward translation. Gene Ther. 20, 121127.
  • Pâques, F. & Duchateau, P. 2007. Meganucleases and DNA double-strand break-induced recombination: perspectives for gene therapy. Curr. Gene Ther. 7, 4966.
  • Pattanayak, V., Ramirez, C. L., Joung, J. K. & Liu, D. R. 2011. Revealing off-target cleavage specificities of zinc-finger nucleases by in vitro selection. Nat. Methods 8, 765770.
  • Perez, E. E., Wang, J., Miller, J. C., Jouvenot, Y., Kim, K. A., Liu, O., Wang, N., Lee, G., Bartsevich, V. V., Lee, Y.-L., Guschin, D. Y., Rupniewski, I., Waite, A. J., Carpenito, C., Carroll, R. G., Orange, J. S., Urnov, F. D., Rebar, E. J., Ando, D., Gregory, P. D., Riley, J. L., Holmes, M. C. & June, C. H. 2008. Establishment of HIV-1 resistance in CD4 +  T cells by genome editing using zinc-finger nucleases. Nat. Biotechnol. 26, 808816.
  • Petek, L. M., Russell, D. W. & Miller, D. G. 2010. Frequent endonuclease cleavage at off-target locations in vivo. Mol. Ther. 18, 983986.
  • Popplewell, L., Koo, T., Leclerc, X., Duclert, A., Mamchaoui, K., Gouble, A., Mouly, V., Voit, T., Pâques, F., Cédrone, F., Isman, O., Yáñez-Muñoz, R. J. & Dickson, G. 2013. Gene correction of a duchenne muscular dystrophy mutation by meganuclease-enhanced exon knock-in. Hum. Gene Ther. 24, 692701.
  • Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y. & Zhang, F. 2013. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity. Cell Available at: http://www.cell.com/abstract/S0092-8674(13)01015-5.
  • Riolobos, L., Hirata, R. K., Turtle, C. J., Wang, P.-R., Gornalusse, G. G., Zavajlevski, M., Riddell, S. R. & Russell, D. W. 2013. HLA Engineering of Human Pluripotent Stem Cells. Mol. Ther. 21, 12321241.
  • Rousseau, J., Chapdelaine, P., Boisvert, S., Almeida, L. P., Corbeil, J., Montpetit, A. & Tremblay, J. P. 2011. Endonucleases: tools to correct the dystrophin gene. J. Gene Med. 13, 522537.
  • Russell, D. W. & Hirata, R. K. 1998. Human gene targeting by viral vectors. Nat. Genet. 18, 325330.
  • Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C. M., Saragosti, S., Lapoumeroulie, C., Cognaux, J., Forceille, C., Muyldermans, G., Verhofstede, C., Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi, Y., Smyth, R. J., Collman, R. G., Doms, R. W., Vassart, G. & Parmentier, M. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382, 722725.
  • Schaub, M. A., Boyle, A. P., Kundaje, A., Batzoglou, S. & Snyder, M. 2012. Linking disease associations with regulatory information in the human genome. Genome Res. 22, 17481759.
  • Sebastiano, V., Maeder, M. L., Angstman, J. F., Haddad, B., Khayter, C., Yeo, D. T., Goodwin, M. J., Hawkins, J. S., Ramirez, C. L., Batista, L. F. Z., Artandi, S. E., Wernig, M. & Joung, J. K. 2011. In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases. Stem Cells 29, 17171726.
  • Smith, J. R., Maguire, S., Davis, L. A., Alexander, M., Yang, F., Chandran, S., Ffrench-Constant, C. & Pedersen, R. A. 2008. Robust, Persistent Transgene Expression in Human Embryonic Stem Cells Is Achieved with AAVS1-Targeted Integration. Stem Cells 26, 496504.
  • Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., Zhang, L., Guschin, D., Fong, L. K., Vu, B. J., Meng, X., Urnov, F. D., Rebar, E. J., Gregory, P. D., Zhang, H. S. & Jaenisch, R. 2011. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 146, 318331.
  • Song, H., Chung, S.-K. & Xu, Y. 2010. Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6, 8089.
  • Suzuki, K., Mitsui, K., Aizawa, E., Hasegawa, K., Kawase, E., Yamagishi, T., Shimizu, Y., Suemori, H., Nakatsuji, N. & Mitani, K. 2008. Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors. Proc. Natl Acad. Sci. 105, 1378113786.
  • Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861872.
  • Tuerk, C. & Gold, L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505510.
  • Tyagi, M. & Bukrinsky, M. 2012. Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication. Mol. Med. 18, 10961108.
  • Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D. & Holmes, M. C. 2005. Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435, 646651.
  • Verhaart, I. E. C. & Aartsma-Rus, A. 2012. Gene therapy for Duchenne muscular dystrophy. Curr. Opin. Neurol. 25, 588596.
  • Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F. & Jaenisch, R. 2013. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910918.
  • Yanover, C. & Bradley, P. 2011. Extensive protein and DNA backbone sampling improves structure-based specificity prediction for C2H2 zinc fingers. Nucleic Acids Res. 39, 45644576.
  • Yusa, K., Rashid, S. T., Strick-Marchand, H., Varela, I., Liu, P.-Q., Paschon, D. E., Miranda, E., Ordóñez, A., Hannan, N. R. F., Rouhani, F. J., Darche, S., Alexander, G., Marciniak, S. J., Fusaki, N., Hasegawa, M., Holmes, M. C., Di Santo, J. P., Lomas, D. A., Bradley, A. & Vallier, L. 2011. Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature 478, 391394.
  • Zou, J., Mali, P., Huang, X., Dowey, S. N. & Cheng, L. 2011. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. Blood 118, 45994608.
  • Zwaka, T. P. & Thomson, J. A. 2003. Homologous recombination in human embryonic stem cells. Nat Biotechnol 21, 319321.